Nantahala Capital Management - Q3 2016 holdings

$829 Million is the total value of Nantahala Capital Management's 67 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 53.0% .

 Value Shares↓ Weighting
IWM SellISHARES TRput$167,064,000
-15.5%
1,345,000
-21.8%
20.14%
-6.0%
SGMS  SCIENTIFIC GAMES CORPcall$51,822,000
+22.6%
4,598,2000.0%6.25%
+36.4%
YHOO BuyYAHOO INC$51,409,000
+31.3%
1,192,776
+14.4%
6.20%
+46.0%
DLB BuyDOLBY LABORATORIES INC$46,033,000
+17.9%
847,907
+3.9%
5.55%
+31.1%
FCFS NewFIRSTCASH INC$38,743,000822,912
+100.0%
4.67%
SODA SellSODASTREAM INTERNATIONAL LTD$35,038,000
+18.5%
1,319,215
-4.8%
4.22%
+31.8%
TBBK BuyBANCORP INC DEL$27,152,000
+195.6%
4,229,213
+177.2%
3.27%
+228.7%
CASH SellMETA FINL GROUP INC$25,776,000
+6.7%
425,271
-10.3%
3.11%
+18.7%
CDXS BuyCODEXIS INC$24,691,000
+10.5%
5,561,082
+0.3%
2.98%
+22.9%
CTRN SellCITI TRENDS INC$23,816,000
+28.0%
1,194,988
-0.3%
2.87%
+42.3%
SGMS SellSCIENTIFIC GAMES CORPcl a$23,305,000
-14.5%
2,067,876
-30.3%
2.81%
-4.9%
SCLN  SCICLONE PHARMACEUTICALS INC$18,138,000
-21.5%
1,769,5580.0%2.19%
-12.7%
QADA BuyQAD INCcl a$17,343,000
+73.5%
774,933
+49.4%
2.09%
+92.9%
AKBA BuyAKEBIA THERAPEUTICS INC$17,331,000
+37.9%
1,915,008
+14.0%
2.09%
+53.3%
ARQL BuyARQULE INC$16,303,000
-4.3%
9,263,041
+3.3%
1.97%
+6.5%
PRTA NewPROTHENA CORPput$13,733,000229,000
+100.0%
1.66%
LXFR BuyLUXFER HLDGS PLCsponsored adr$13,654,000
+6.1%
1,178,078
+10.2%
1.65%
+18.0%
ORM SellOWENS RLTY MTG INC$13,490,000
-11.5%
778,867
-15.0%
1.63%
-1.6%
GDEN SellGOLDEN ENTMT INC$11,757,000
+1.4%
942,786
-5.0%
1.42%
+12.8%
FCAU BuyFIAT CHRYSLER AUTOMOBILES Ncall$11,493,000
+88.6%
1,795,800
+80.3%
1.39%
+109.7%
BPI SellBRIDGEPOINT ED INC$11,362,000
-17.2%
1,653,826
-12.8%
1.37%
-7.9%
 IMPERIAL HLDGS INCnote 8.500% 2/1$10,716,000
-0.1%
11,970,0000.0%1.29%
+11.2%
RH NewRESTORATION HARDWARE HLDGS Icall$10,374,000300,000
+100.0%
1.25%
RACE  FERRARI N V$9,834,000
+26.7%
189,5820.0%1.19%
+41.0%
RH  RESTORATION HARDWARE HLDGS I$9,436,000
+20.6%
272,8760.0%1.14%
+34.2%
PIP SellPHARMATHENE INC$9,286,000
+17.0%
3,202,045
-1.5%
1.12%
+30.2%
SRPT  SAREPTA THERAPEUTICS INCcall$9,212,000
+222.0%
150,0000.0%1.11%
+258.4%
CCN NewCARDCONNECT CORP$9,172,000938,808
+100.0%
1.11%
EZPW SellEZCORP INCcl a non vtg$7,780,000
-26.9%
703,471
-50.0%
0.94%
-18.6%
CRMT SellAMERICAS CAR MART INC$7,364,000
+14.3%
202,350
-11.3%
0.89%
+27.2%
ERI NewELDORADO RESORTS INC$6,465,000459,793
+100.0%
0.78%
TWMC  TRANS WORLD ENTMT CORP$6,155,000
-8.0%
1,784,0340.0%0.74%
+2.3%
CGNT BuyCOGENTIX MED INC$6,051,000
+100.6%
3,324,877
+6.1%
0.73%
+123.2%
EPM  EVOLUTION PETROLEUM CORP$5,673,000
+14.8%
903,2820.0%0.68%
+27.6%
CXW NewCORRECTIONS CORP AMER NEWput$5,548,000400,000
+100.0%
0.67%
 EZCORP INCnote 2.625% 6/1$5,476,000
+18.5%
5,500,0000.0%0.66%
+31.7%
EMGCQ  EMERGENT CAP INC$5,408,000
-12.8%
1,845,6590.0%0.65%
-3.0%
LINC BuyLINCOLN EDL SVCS CORP$4,981,000
+50.9%
2,263,899
+2.9%
0.60%
+67.9%
RBCAA SellREPUBLIC BANCORP KYcl a$4,714,000
-10.8%
151,658
-20.7%
0.57%
-0.9%
RLGT SellRADIANT LOGISTICS INC$4,546,000
-40.6%
1,600,665
-37.2%
0.55%
-34.0%
ONDK BuyON DECK CAP INC$4,153,000
+36.1%
728,564
+23.0%
0.50%
+51.4%
PTIE SellPAIN THERAPEUTICS INC$3,870,000
-69.2%
3,870,832
-32.5%
0.47%
-65.7%
FALC SellFALCONSTOR SOFTWARE INC$3,528,000
-1.0%
3,392,318
-0.0%
0.42%
+10.1%
DVD BuyDOVER MOTORSPORTS INC$3,038,000
+16.9%
1,229,789
+2.7%
0.37%
+29.8%
CCXI BuyCHEMOCENTRYX INC$2,817,000
+46.3%
466,440
+8.8%
0.34%
+62.7%
ERI NewELDORADO RESORTS INCcall$2,678,000190,500
+100.0%
0.32%
CXW NewCORRECTIONS CORP AMER NEWcall$2,183,000157,400
+100.0%
0.26%
EMMS NewEMMIS COMMUNICATIONS CORP$1,386,000342,193
+100.0%
0.17%
DDE BuyDOVER DOWNS GAMING & ENTMT I$1,362,000
+19.9%
1,261,253
+17.7%
0.16%
+33.3%
STRM NewSTREAMLINE HEALTH SOLUTIONS$1,273,000692,108
+100.0%
0.15%
TA  TRAVELCENTERS AMER LLC$1,092,000
-12.2%
152,5110.0%0.13%
-2.2%
FBK NewFB FINL CORP$1,009,00050,000
+100.0%
0.12%
STRL NewSTERLING CONSTRUCTION CO INC$978,000126,337
+100.0%
0.12%
MFCB  MFC BANCORP LTD$693,000
-6.4%
337,9780.0%0.08%
+5.0%
OCN  OCWEN FINL CORPcall$683,000
+114.8%
186,0000.0%0.08%
+141.2%
CCNWW NewCARDCONNECT CORP*w exp 07/29/202$488,000447,363
+100.0%
0.06%
PHMD NewPHOTOMEDEX INC$357,000276,958
+100.0%
0.04%
CASLQ  CASTLE A M & CO$108,000
-51.1%
134,7640.0%0.01%
-45.8%
UTI SellUNIVERSAL TECHNICAL INST INC$55,000
-50.5%
30,825
-37.1%
0.01%
-41.7%
FNTCW ExitFINTECH ACQUISITION CORP*w exp 02/19/202$0-397,363
-100.0%
-0.03%
PHMD ExitPHOTOMEDEX INC$0-1,384,777
-100.0%
-0.04%
WHF ExitWHITEHORSE FIN INC$0-57,132
-100.0%
-0.07%
EMMS ExitEMMIS COMMUNICATIONS CORPcl a$0-1,368,777
-100.0%
-0.11%
SXCP ExitSUNCOKE ENERGY PARTNERS L P$0-97,375
-100.0%
-0.11%
ESINQ ExitITT EDUCATIONAL SERVICES INCcall$0-1,000,000
-100.0%
-0.21%
CSH ExitCASH AMER INTL INC$0-48,394
-100.0%
-0.22%
RM ExitREGIONAL MGMT CORP$0-172,974
-100.0%
-0.28%
SXC ExitSUNCOKE ENERGY INC$0-464,182
-100.0%
-0.29%
FCAU ExitFIAT CHRYSLER AUTOMOBILES N$0-543,952
-100.0%
-0.36%
ESINQ ExitITT EDUCATIONAL SERVICES INC$0-2,063,792
-100.0%
-0.43%
FNTC ExitFINTECH ACQUISITION CORP$0-397,363
-100.0%
-0.43%
QADB ExitQAD INCcl b$0-245,765
-100.0%
-0.46%
M ExitMACYS INC$0-150,000
-100.0%
-0.55%
SFR ExitCOLONY STARWOOD HOMES$0-255,951
-100.0%
-0.84%
CROX ExitCROCS INC$0-1,118,223
-100.0%
-1.37%
IWM ExitISHARES TRcall$0-120,000
-100.0%
-1.50%
QQQ ExitPOWERSHARES QQQ TRUSTput$0-250,000
-100.0%
-2.92%
FCFS ExitFIRST CASH FINL SVCS INC$0-787,073
-100.0%
-4.38%
DRII ExitDIAMOND RESORTS INTL INCcall$0-1,400,000
-100.0%
-4.55%
DRII ExitDIAMOND RESORTS INTL INC$0-1,699,487
-100.0%
-5.52%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-11-14
Signatures

The EDGAR filing(s) were signed by:

About Nantahala Capital Management

Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.

Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.

Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.

Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR42Q3 202327.2%
CODEXIS INC42Q3 20233.9%
PATHWARD FINANCIAL INC35Q3 20236.3%
SCIENTIFIC GAMES CORP34Q3 20225.3%
DOVER MOTORSPORTS INC34Q3 20210.5%
GOLDEN ENTMT INC33Q3 20232.1%
QAD INC32Q3 20212.6%
SCIENTIFIC GAMES CORP31Q4 20217.7%
DOLBY LABORATORIES INC31Q4 20205.6%
LINCOLN EDL SVCS CORP31Q4 20210.7%

View Nantahala Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Nantahala Capital Management Q3 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AYTU BIOPHARMA, INCJune 16, 20231,086,81219.7%
Acer Therapeutics Inc.February 14, 20231,226,1917.5%
Aeglea BioTherapeutics, Inc.February 14, 20234,611,3027.5%
AKUMIN INC.February 14, 20232,206,9602.5%
ALTA EQUIPMENT GROUP INC.February 14, 20231,188,9853.7%
Apollo Endosurgery, Inc.February 14, 20234,056,6279.9%
Autolus Therapeutics plcFebruary 14, 20237,782,0184.7%
Bioventus Inc.February 14, 20233,168,5745.1%
CATALYST BIOSCIENCES, INC.February 14, 2023438,0551.4%
Drive Shack Inc.February 14, 20236,500,0007.0%

View Nantahala Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-21
42024-03-15
SC 13G2024-03-11
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Nantahala Capital Management's complete filings history.

Compare quarters

Export Nantahala Capital Management's holdings